Powering Reliable Vaccine and Vector Production;Welcome to Nuvonis Technologies.

Nuvonis Technologies is your trusted partner in biotech, providing high-quality, innovative cell banks for vaccine and vector production. Our experienced team offers in-depth technical support across virus production processes, from vaccine strain improvement to comprehensive analytical services, ensuring a smooth and efficient development journey.

GMP Cell Banks You Can Depend On:
Nuvonis offers "ready to use" GMP Master and Working Cell Banks produced under serum- and animal-free conditions, guaranteeing quality and safety. Fully characterized, including end-of-production tumorigenicity testing, these cell banks are immediately available for your GMP manufacturing needs.

Advancing Vaccine Production with Innovative Avian Cell Lines:
Explore the potential of our continuous avian cell line, CCX, derived from primary quail cells. Available in both adherent (CCX.2C4) and suspension (CCX.E10) formats, our Avian Cell Banks provide a reliable and scalable alternative to traditional CEF or egg-based methods.

Your Partner in Process Development Excellence:
Rely on the Nuvonis team's extensive experience in developing and optimizing vaccine production processes. We offer a proprietary, high-efficiency virus purification process for superior vaccine purity, alongside tailored analytical services, analytical development, and seamless transfer of virus and viral vector assays (e.g., FFA).

Nuvonis Technologies GmbH

Org chart

Teams

Offices